BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.380
+0.020 (1.47%)
At close: Mar 9, 2026, 4:00 PM EDT
1.390
+0.010 (0.72%)
After-hours: Mar 9, 2026, 4:00 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $10.48 million as of March 9, 2026. Its market cap has decreased by -65.18% in one year.
Market Cap
10.48M
Enterprise Value
-9.74M
1-Year Change
-65.18%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $10.48M, a decrease of -79.84%. That is a compound annual growth rate of -25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.30M | 18.39% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 11.57M |
| CalciMedica | 11.45M |
| Akari Therapeutics, | 11.37M |
| Imunon | 11.02M |
| BiomX | 10.85M |
| Liminatus Pharma | 10.42M |
| Longeveron | 10.32M |
| Moleculin Biotech | 10.26M |